Clinical Trial Update: Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS) [Phase 4]

View source ↗

Summary

Phase 4 trial update of the ADIDAS study, examining whether dapagliflozin-related improvements are associated with anemia in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Heart Failure

Drugs mentioned

• Forxiga (dapagliflozin) (dapagliflozin)

Snippet

Sponsor: Xiangtan Central Hospital | Conditions: Anemia, Heart Failure | Phase 4 | Status: RECRUITING